VIR BIOTECHNOLOGY INC (VIR)
Sector: Health Care
Named Executive Officers
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Marianne De Backer, M.Sc., Ph.D., MBA President, Chief Executive Officer and Director | 2025 | $950,000 | $0 | $2,296,800 | $3,507,360 | $1,002,750 | $77,135 | $7,834,045 |
| 2024 | $920,833 | $2,500,000 | $1,769,250 | $2,697,800 | $1,021,200 | $346,820 | $9,255,903 | |
| 2023 | $675,000 | $2,500,000 | $13,419,803 | $21,604,153 | $855,360 | $437,179 | $39,491,495 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Mark Eisner, M.D., M.P.H. Executive Vice President and Chief Medical Officer | 2025 | $660,833 | $375,000 | $382,800 | $584,560 | $354,291 | $14,000 | $2,371,484 |
| 2024 | $379,167 | $375,000 | $702,750 | $1,075,095 | $221,130 | $3,123 | $2,756,265 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Jason O'Byrne, MBA Executive Vice President and Chief Financial Officer | 2025 | $534,417 | $150,000 | $382,800 | $584,560 | $286,051 | $14,000 | $1,951,828 |
| 2024 | $130,492 | $150,000 | $648,000 | $991,335 | $0 | $0 | $1,919,827 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Vanina de Verneuil, J.D. Executive Vice President, General Counsel and Corporate Secretary | 2025 | $506,333 | $0 | $334,950 | $511,490 | $329,648 | $8,363 | $1,690,784 |
| 2024 | $486,667 | $300,000 | $227,475 | $346,860 | $296,352 | $12,117 | $1,669,471 |